S&P 500 (NYSE:SPY) component Mylan Inc. (NASDAQ:MYL) reported its results for the third quarter. Mylan is a global pharmaceutical company that develops, licenses, manufactures, markets, and distributes pharmaceuticals and active pharmaceutical ingredients.
Earnings season is back and more important than ever. Get our newest CHEAT SHEET stock picks now
Mylan Inc. Earnings Cheat Sheet
Results: Net income for Mylan Inc. rose to $212 million (51 cents per share) vs. $156.7 million (36 cents per share) in the same quarter a year earlier. This marks a rise of 35.3% from the year-earlier quarter.
Revenue: Rose 14.9% to $1.81 billion from the year-earlier quarter.
Actual vs. Wall St. Expectations: Mylan Inc. fell short of the mean analyst estimate of 77 cents per share. It beat the average revenue estimate of $1.66 billion.
Quoting Management: Mylan Chief Executive Officer, Heather Bresch commented: “Mylan delivered another outstanding quarter of top- and bottom-line growth, with strong double-digit growth in our Specialty, North America, and Asia Pacific businesses and a return to growth in EMEA. It is notable that we delivered adjusted diluted EPS for this one quarter in excess of our earnings for all of 2008-the first full year following our Matrix and Merck KGaA generics acquisitions-providing further evidence of our ability to generate optimal organic growth from our global scale and operating leverage.”
Revenue has risen the past four quarters. Revenue increased 7.5% to $1.69 billion in the second quarter. The figure rose 9.9% in the first quarter from the year earlier and climbed 6.7% in the fourth quarter of the last fiscal year from the year-ago quarter.
After beating analyst estimates for the two previous quarters, the company fell short of forecasts. In the second quarter, it topped the mark by 5 cents, and in the first quarter, it was ahead by one cent.
Net income has increased more than twofold year-over-year on average across the last five quarters. The biggest gain came in the fourth quarter of the last fiscal year, when income climbed more than sixfold from the year-earlier quarter.
Looking Forward: Expectations for the fourth quarter have not changed from 64 cents. Over the past three months, the average estimate for the fiscal year has climbed from $2.51 per to share to $2.52.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute — click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories: